File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Cervical priming with oral misoprostol in pre-labor rupture of membranes at term

TitleCervical priming with oral misoprostol in pre-labor rupture of membranes at term
Authors
Issue Date1996
PublisherLippincott Williams & Wilkins. The Journal's web site is located at http://www.greenjournal.org
Citation
Obstetrics And Gynecology, 1996, v. 87 n. 6, p. 923-926 How to Cite?
AbstractObjective: To investigate the effectiveness of oral misoprostol as a cervical priming agent for patients presenting with pre-labor rupture of membranes at term. Methods: Eighty patients presenting with pre-labor rupture of membranes at term were randomized to receive either 200 μg of misoprostol or 50 mg of vitamin B 6 orally 1 hour after admission. Labor was induced with intravenous oxytocin infusion 12 hours after oral medication if the patient did not go into labor. We compared the induction rate, duration of labor, mode of delivery, and leaking-to-delivery interval in the two groups. Results: The cervical score was significantly improved and the induction rate was also reduced in the misoprostol group when compared with the control group. The interval from recruitment to onset of labor, duration of labor, and the interval from recruitment to delivery were significantly shorter in the misoprostol group. The mode of delivery and the perinatal outcome were similar for the two groups. Conclusion: Oral misoprostol is an effective agent for cervical priming and labor induction in patients with pre-labor rupture of membranes at term.
Persistent Identifierhttp://hdl.handle.net/10722/173050
ISSN
2015 Impact Factor: 5.656
2015 SCImago Journal Rankings: 2.899
References

 

DC FieldValueLanguage
dc.contributor.authorNgai, SWen_US
dc.contributor.authorTo, WKen_US
dc.contributor.authorLao, Ten_US
dc.contributor.authorHo, PCen_US
dc.date.accessioned2012-10-30T06:27:40Z-
dc.date.available2012-10-30T06:27:40Z-
dc.date.issued1996en_US
dc.identifier.citationObstetrics And Gynecology, 1996, v. 87 n. 6, p. 923-926en_US
dc.identifier.issn0029-7844en_US
dc.identifier.urihttp://hdl.handle.net/10722/173050-
dc.description.abstractObjective: To investigate the effectiveness of oral misoprostol as a cervical priming agent for patients presenting with pre-labor rupture of membranes at term. Methods: Eighty patients presenting with pre-labor rupture of membranes at term were randomized to receive either 200 μg of misoprostol or 50 mg of vitamin B 6 orally 1 hour after admission. Labor was induced with intravenous oxytocin infusion 12 hours after oral medication if the patient did not go into labor. We compared the induction rate, duration of labor, mode of delivery, and leaking-to-delivery interval in the two groups. Results: The cervical score was significantly improved and the induction rate was also reduced in the misoprostol group when compared with the control group. The interval from recruitment to onset of labor, duration of labor, and the interval from recruitment to delivery were significantly shorter in the misoprostol group. The mode of delivery and the perinatal outcome were similar for the two groups. Conclusion: Oral misoprostol is an effective agent for cervical priming and labor induction in patients with pre-labor rupture of membranes at term.en_US
dc.languageengen_US
dc.publisherLippincott Williams & Wilkins. The Journal's web site is located at http://www.greenjournal.orgen_US
dc.relation.ispartofObstetrics and Gynecologyen_US
dc.rightsObstetrics and Gynecology. Copyright © Lippincott Williams & Wilkins.-
dc.subject.meshAdministration, Oralen_US
dc.subject.meshAdulten_US
dc.subject.meshCervix Uteri - Drug Effectsen_US
dc.subject.meshDelivery, Obstetricen_US
dc.subject.meshDouble-Blind Methoden_US
dc.subject.meshFemaleen_US
dc.subject.meshFetal Membranes, Premature Rupture - Therapyen_US
dc.subject.meshHumansen_US
dc.subject.meshLabor, Induceden_US
dc.subject.meshMisoprostol - Administration & Dosageen_US
dc.subject.meshOxytocics - Administration & Dosageen_US
dc.subject.meshOxytocin - Administration & Dosageen_US
dc.subject.meshPregnancyen_US
dc.subject.meshPyridoxine - Administration & Dosageen_US
dc.subject.meshTime Factorsen_US
dc.titleCervical priming with oral misoprostol in pre-labor rupture of membranes at termen_US
dc.typeArticleen_US
dc.identifier.emailHo, PC:pcho@hku.hken_US
dc.identifier.authorityHo, PC=rp00325en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1016/0029-7844(96)00072-5en_US
dc.identifier.pmid8649699-
dc.identifier.scopuseid_2-s2.0-0003037437en_US
dc.identifier.hkuros14295-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0003037437&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume87en_US
dc.identifier.issue6en_US
dc.identifier.spage923en_US
dc.identifier.epage926en_US
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridNgai, SW=7006074214en_US
dc.identifier.scopusauthoridTo, WK=7004294515en_US
dc.identifier.scopusauthoridLao, T=35327208900en_US
dc.identifier.scopusauthoridHo, PC=7402211440en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats